Navigation Links
JCI online early table of contents: Dec. 1, 2008
Date:12/1/2008

EDITOR'S PICK: Harnessing miRNA natural gene repressors for anticancer therapy

Michel Sadelain and colleagues, at Memorial Sloan-Kettering Cancer Center, New York, have developed a new approach to modulate the expression of genes for therapeutic purposes, and used this to mediate effective anticancer therapy in mice.

Small, noncoding RNA molecules known as miRNAs are powerful natural repressors of gene expression. In the study, the miRNA miR-181a was harnessed to segregate expression of genes in immune cells known as T cells at different stages of their development. miR-181a is highly expressed in developing T cells, in which it represses expression of many genes, and markedly downregulated in mature T cells. Sadelain and colleagues engineered mouse bone marrow cells to express therapeutic genes only when miR-181a expression is downregulated. These cells were then transplanted into mice and allowed to develop into mature T cells. Expression of the genes (and therefore the proteins made from the genes) was not detected in developing T cells, i.e., when miR-181a was highly expressed, but was detected in mature T cells, i.e., when miR-181a was downregulated. When the genes controlled by miR-181a were responsible for making proteins that target T cells to tumor cells expressing the protein hCD19, the mice that were transplanted with the engineered bone marrow cells were able to reject tumors expressing hCD19. The authors therefore suggest that it might be possible to harness miRNA-regulated therapeutic gene expression in stem cellbased therapies, including cancer immunotherapy.

TITLE: Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras

AUTHOR CONTACT:
Michel Sadelain
Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Phone: (212) 639-6190; Fax: (917) 432-2340; E-mail:

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. HIV denialists spread misinformation online -- consequences could be deadly; and more
2. Consequences of online HIV denial; and more
3. Online Epidemic Gives Clues to Bird Flu Spread
4. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
5. Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding
6. Syndicom to Launch Online Community for DePuy Spine
7. Elder Caregiving Site ShirleyBOARD.com Wins WebAward for Outstanding Online Community
8. Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning
9. CIGNA Behavioral Health Offers Members Online Provider Profiles
10. Dynamic Energy Systems Goes Online and On-Demand
11. North Shore-LIJ Health System Begins Online Posting of Hospital Infection Rates, Other Performance Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 2015 Atagi Plastic Surgery and Skin ... an Ultherapy® Ultra Treatment Provider by Ulthera, ... Aesthetics is one of only six practices in Colorado ... provider. , Atagi Plastic Surgery and Skin Aesthetics’ ... has led the practice to earn the distinction of ...
(Date:6/1/2015)... The Muscular Dystrophy Association is offering an ... the sold out 2015 Bank of America Chicago ... by signing up through the organization's nationwide endurance ... , This national endurance program includes world-class training ... a supportive community of teammates, volunteers, coaches and ...
(Date:6/1/2015)... Note: Dr. Julian is available for interviews ... , A phase III trial funded by the National ... carcinoma in situ (DCIS) now have an additional tool ... (NSABP B-35/NRG Oncology) looked at more than 3,000 DCIS ... with tamoxifen to those who completed five years of ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Northridge ... are now offering patients a promotion on Invisalign for ... of Invisalign treatment is reduced to $3,700. Patients can ... the complimentary consultation and discuss the extent of correction ... it cannot be combined with any other offer. ...
(Date:6/1/2015)... InstantLabs will co-develop and commercialize a ... a Cooperative Research and Development Agreement (CRADA) with the ... with U.S. Farm Bill legislation, only members of the ... the United States. , InstantLabs’ DNA-based technology will ... need rather than requiring samples be sent to centralized ...
Breaking Medicine News(10 mins):Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2Health News:Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:Northridge Dentists, Drs. Michel Elyson and Ramin Assili, are Now Offering a Limited Time Promotion on Invisalign 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 3Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 4
... 2011 Egocentric, self-centred, and insensitive to the needs ... with severe traumatic brain injury (TBI) and have been ... the capacity to recognise and understand the emotions of ... more common, and resulting empathy deficits can have negative ...
... Maryland, June 28, 2011 Nurses on a surgical ... center cut bloodstream infections to zero and saved more ... of Maryland Medical Center SICU sustained a rate of ... period, eliminating 14 CLABSIs and saving 2-3 lives when ...
... from Wayne State University, and her mentor, Lisa J. Rapport, ... Liberal Arts and Sciences, found that if traumatic brain injury ... help them rehabilitate. The study was recently published in ... disruption of normal brain function after a head injury and ...
... Americans and the rest of the nation have been ... blacks who identify as members of the Seventh-day Adventist ... the average American. Researchers point to certain lifestyle behaviors ... was conducted at Loma Linda University as part of ...
... today,s society where access to media is ever present, many ... children and how media consumption can potentially affect them. Two ... and Dr. Michelle M. Garrison, PhD of Seattle Children,s Research ... media usage can lead to depression in college students and ...
... battle to lose inches or at least stay the same, ... 25 and 27 at the American Diabetes Association,s Scientific Sessions ... Epidemiologists from the School of Medicine at The ... showing that diet soft drink consumption is associated with increased ...
Cached Medicine News:Health News:Lack of empathy following traumatic brain injury linked to reduced responsiveness to anger 2Health News:Intensive, hands-on effort reduces bloodstream infections in critically ill patients 2Health News:Religion benefits traumatic brain injury victims, Wayne State University research finds 2Health News:Black members of Adventist church defy health disparities, study shows 2Health News:Studies examine impact of media use among youth, recommend preventative measures 2Health News:Studies examine impact of media use among youth, recommend preventative measures 3Health News:Related studies point to the illusion of the artificial 2Health News:Related studies point to the illusion of the artificial 3
(Date:6/1/2015)... About Pressure Relief Devices ... and improve the quality life of patients who suffer ... a significant role in inhibiting the growth and treatment ... turn or rotate an immobile patient by providing all ... and specialty beds. These devices have the ability to ...
(Date:6/1/2015)... MECHANICSBURG, Pa. , June 1, 2015 ... announced that MJ Acquisition Corporation, a joint venture that ... Stowe XII, L.P., has completed its previously announced acquisition ... in the new joint venture. About ... leading operator of specialty hospitals and outpatient rehabilitation clinics ...
(Date:6/1/2015)... MENLO PARK, Calif. , June ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, today ... clinical trial of  VAL-083  (dianhydrogalactitol) in patients with ... deadly form of human brain cancer. ...
Breaking Medicine Technology:Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8